cytarabine and ponatinib

cytarabine has been researched along with ponatinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Billingham, L; Brock, K; Copland, M; Siddique, S; Sirovica, M; Yap, C	1
Cardarelli, L; Chiaretti, S; Diverio, D; Foà, R; Giona, F; Mancini, F; Miano, M; Moleti, ML; Nanni, M; Palumbo, G; Peragine, N; Santopietro, M; Testi, AM; Zhang, K	1

Trials

1 trial(s) available for cytarabine and ponatinib

Article	Year
Implementing the EffTox dose-finding design in the Matchpoint trial. BMC medical research methodology, 2017, Jul-20, Volume: 17, Issue:1 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Blast Crisis; Cytarabine; Humans; Idarubicin; Imidazoles; Models, Statistical; Outcome Assessment, Health Care; Pyridazines; Research Design; Vidarabine	2017

Other Studies

1 other study(ies) available for cytarabine and ponatinib

Article	Year
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia. Acta haematologica, 2019, Volume: 142, Issue:3 Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Prednisolone; Pyridazines	2019

Article

Year

Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.

Acta haematologica, 2019, Volume: 142, Issue:3

Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Prednisolone; Pyridazines

2019